Browse the evidence

Meal replacement with caloric restriction resulted in greater reductions in body weight and BMI compared to meal replacement without caloric restriction.

Incorporating caloric restriction into meal replacement strategies can enhance weight loss outcomes for T2D patients.

Participants in the DSMES program experienced significant reductions in weight, BMI, and A1C levels.

Implementing a community-based DSMES program can lead to significant health improvements in patients with type 2 diabetes.

The ELM trial tests the hypothesis that a habit-based lifestyle treatment can produce sustained remission of metabolic syndrome (MetS) at 24 months.

Practitioners may consider implementing habit-based lifestyle interventions for MetS management.

Both GLP-1RAs and combination therapy resulted in significant weight loss, with GLP-1RAs showing a mean weight loss of −5.2 kg at 12 months.

Practitioners can expect GLP-1RAs to aid in weight management for liver transplant recipients with diabetes.

VLCHF and LF diets with moderate energy restriction demonstrate similar weight loss and improvements to BP to 3 months.

Both VLCHF and LF diets can be effective for weight loss in the short term.

All groups achieved significant weight loss and improvements in BP and blood glucose.

Both VLCHF and LF diets can lead to significant health improvements.

The automated, online, behavioral obesity treatment program (Rx Weight Loss) produced a mean estimated weight loss of 3.60 kg at 3 months.

Practitioners can consider automated online programs as effective for initial weight loss.

At 12 months, weight regain was significantly less in the monthly and refresher maintenance groups compared to the newsletter control group.

Ongoing maintenance interventions are essential to prevent weight regain after initial weight loss.

The pragmatic implementation of the Rx Weight Loss program resulted in clinically significant weight loss over 2 years.

Clinicians can implement automated online obesity treatments for sustained weight management.

A 28-day carbohydrate-restricted diet resulted in a decrease in body fat by approximately 2.4 kg.

Implementing a carbohydrate-restricted diet may help firefighters reduce body fat.

Performance in a 2.41-km run and pull-up test improved after the carbohydrate-restricted diet.

Firefighters may enhance their physical performance through a carbohydrate-restricted diet.

GLP-1s reduce body weight by 5% to 18% in trials.

Clinicians can expect significant weight loss in patients using GLP-1s.

The position statement reviews current knowledge and gaps regarding exercise and management issues for athletes with diabetes.

This statement can guide healthcare professionals in addressing exercise-related concerns for diabetic athletes.

This systematic evaluation provides evidence-based quantitative estimates of the effects of major dietary factors on CVD and diabetes.

Practitioners can rely on these estimates for understanding dietary impacts on health.

Ten days of low energy availability (LEA) resulted in impaired performance in trained females, with reductions in muscle glycogen content and physical performance parameters.

Athletes should be cautious about using low energy availability strategies as they may impair performance.

Maximizing exercise-induced muscle hypertrophy requires an energy surplus.

Practitioners should ensure that athletes are in a caloric surplus to optimize muscle growth.

Gains in muscle mass can be achieved under hypocaloric conditions.

While muscle gain is possible in a deficit, a surplus is recommended for optimal results.

A 2-month very low energy diet (VLED) resulted in a reduction of waist circumference by 10.6 cm and total weight loss of 12.9 kg in obese patients with obstructive sleep apnea (OSA).

Implementing a VLED can lead to significant weight loss and waist circumference reduction in obese patients with OSA.

A structured weight loss maintenance program incorporating commonly used diets was feasible, tolerable, and efficacious for 10 months after rapid weight loss.

Practitioners can consider structured maintenance diets to support weight loss in OSA patients.

The study provides a comprehensive evaluation of the effects of semaglutide for obesity or overweight.

Clinicians can refer to this study for a balanced view of semaglutide's effects.

Performing cardiovascular exercise early in the morning on an empty stomach may enhance fat mobilization for fuel.

Practitioners may consider recommending morning cardio on an empty stomach for fat loss.

HU6 treatment for 19 weeks significantly decreased body weight by -2.86 kg compared to placebo (P = .003).

HU6 may be an effective treatment option for weight loss in patients with obesity-related HFpEF.

HU6 treatment significantly decreased total fat mass by -2.96 kg compared to placebo (P < .001).

HU6 may help reduce fat mass in patients with obesity-related HFpEF.

Recommendations for dietary guidelines should be expressed in terms of foods and not macronutrients.

Practitioners should focus on food-based dietary recommendations rather than macronutrient ratios.